Adding Cinacalcet Shown Not to Slow Vascular Calcification in Hemodialysis
Overall control of hyperparathyroidism and hyperphosphatemia appeared to be associated with a reduction in left ventricular mass, however.
Diagnosis & Disease Information
Tenapanor May Improve Phosphate Normalization in the Dialysis Population
Tenapanor inhibits the sodium hydrogen exchanger 3 (NHE3), reducing paracellular uptake of phosphate in the intestine.
Study: Roxadustat Effectively Treats Anemia Across CKD Stages
Roxadustat reduced the need for rescue therapy among patients with any stage of chronic kidney disease.
Pegloticase Use for Uncontrolled Gout in the Dialysis Population Described
New study is the first to characterize pegloticase use in the dialysis population.
Low Potassium Dialysate May Improve Inpatient Survival
Modifying the potassium concentration used for dialysis may decrease mortality risk among hospitalized patients with end-stage kidney disease and severe hyperkalemia, according to investigators.
Nicotinamide May Improve Phosphate Control in Hemodialysis Patients
Nicotinamide modulates expression of the sodium-dependent phosphate cotransporter 2b and thereby may inhibit intestinal phosphate absorption, according to investigators.
Conservative CKD-MBD Management at Dialysis Initiation on the Rise
Trends suggest that clinical practice could be driven heavily by providers’ preferences and beliefs, resulting in substantial practice variation.
Co-Dispensing of Benzodiazepines and Opioids Dangerous in HD
Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
Canagliflozin decreases the risk of kidney failure in patients with chronic kidney disease and type 2 diabetes, according to a new study.
